Guizhou Yibai Pharmaceutical Co., Ltd. (600594.SS)
CNY 4.08
(-1.69%)
CNY 4.08
(-1.69%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.77 Billion | 2.73 Billion | 3.34 Billion | 3.41 Billion | 3.36 Billion | 3.88 Billion |
| Cost of Revenue | 935.74 Million | 794.22 Million | 711.05 Million | 707.3 Million | 735.6 Million | 1.07 Billion |
| Gross Profit | 1.84 Billion | 1.94 Billion | 2.63 Billion | 2.7 Billion | 2.62 Billion | 2.8 Billion |
| Operating Expenses | 1.73 Billion | 1.67 Billion | 2.13 Billion | 2.2 Billion | 2.29 Billion | 2.44 Billion |
| Selling, General and Administrative Expenses | 1.52 Billion | 1.35 Billion | 1.79 Billion | 1.84 Billion | 1.95 Billion | 2.12 Billion |
| Research and Development Expenses | 118.06 Million | 126.93 Million | 136.07 Million | 145.99 Million | 118.54 Million | 76.77 Million |
| Other Expenses | - | 191.51 Million | 200.14 Million | 213.92 Million | 225.81 Million | -7.99 Million |
| Cost and Expenses | 2.63 Billion | 2.46 Billion | 2.84 Billion | 2.91 Billion | 3.03 Billion | 3.51 Billion |
| Operating Income | 145.51 Million | 257.33 Million | 536.13 Million | 486.56 Million | 377.76 Million | -777.95 Million |
| Interest Expense | 21.64 Million | 37.47 Million | 35.13 Million | 41.26 Million | 51.45 Million | 73.13 Million |
| Income Tax Expense | 40.96 Million | 46.26 Million | 79.57 Million | 86.13 Million | 75.9 Million | -101.45 Million |
| Earnings before Tax | 132.32 Million | -392.06 Million | 310.36 Million | 297.47 Million | 208.32 Million | -785.94 Million |
| Net Income | 103.39 Million | -438.32 Million | 243.77 Million | 219.89 Million | 141.89 Million | -725.49 Million |
| Earnings Per Share Basic | 0.13 | -0.55 | 0.31 | 0.29 | 0.18 | -0.92 |
| Earnings Per Share Diluted | 0.13 | -0.55 | 0.31 | 0.29 | 0.18 | -0.92 |
| Weighted Average Shares Outstanding | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million | 792.02 Million |
| Gross Margin | 0.66 | 0.71 | 0.79 | 0.79 | 0.78 | 0.72 |
| EBIT Margin | 0.13 | 0.16 | 0.21 | 0.18 | 0.16 | 0.14 |
| Profit Margin | 0.04 | -0.16 | 0.07 | 0.06 | 0.04 | -0.19 |
| EBITDA | 355.07 Million | -122.81 Million | 552.27 Million | 519.85 Million | 452.05 Million | -483.23 Million |
| Earnings Before Tax Margin | 0.05 | 0.09 | 0.16 | 0.14 | 0.11 | -0.20 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 545.64 Million | 588.51 Million | 563.14 Million | 675.01 Million | 2.77 Billion | 657.13 Million |
| Cost of Revenue | 209.23 Million | 229.06 Million | 225.76 Million | 250.09 Million | 930.11 Million | 202.19 Million |
| Gross Profit | 336.41 Million | 359.44 Million | 337.38 Million | 424.91 Million | 1.84 Billion | 454.94 Million |
| Operating Expenses | 359.34 Million | 399.29 Million | 402.14 Million | 491.81 Million | 1.7 Billion | 396.49 Million |
| Selling, General and Administrative Expenses | 524.38 Million | 364.7 Million | 369.03 Million | 389.69 Million | - | 461.65 Million |
| Research and Development Expenses | 27.02 Million | 26.64 Million | 22.79 Million | 35.49 Million | - | 25.48 Million |
| Other Expenses | -192.06 Million | -7.95 Million | -10.32 Million | -66.62 Million | -72.92 Million | -2.29 Million |
| Cost and Expenses | 568.57 Million | 628.36 Million | 627.91 Million | 741.91 Million | 2.63 Billion | 598.68 Million |
| Operating Income | -57.03 Million | -39.85 Million | -64.76 Million | -66.89 Million | 145.51 Million | 43.56 Million |
| Interest Expense | 5.22 Million | 6.43 Million | 9.61 Million | 7.24 Million | 21.64 Million | 9.59 Million |
| Income Tax Expense | 3.52 Million | -4.69 Million | 1.64 Million | 7.55 Million | 40.96 Million | 1.49 Million |
| Earnings before Tax | -59.74 Million | -44.35 Million | -69.82 Million | -62.5 Million | 132.66 Million | 41.26 Million |
| Net Income | -62.65 Million | -38.03 Million | -68.45 Million | -66.47 Million | 103.39 Million | 41.96 Million |
| Earnings Per Share Basic | -0.08 | -0.05 | -0.09 | -0.08 | - | 0.05 |
| Earnings Per Share Diluted | -0.08 | -0.05 | -0.09 | -0.08 | - | 0.05 |
| Weighted Average Shares Outstanding | 786.89 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million |
| Weighted Average Shares Outstanding (Diluted) | 786.89 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million | 791.92 Million |
| Gross Margin | 0.62 | 0.61 | 0.60 | 0.63 | 0.67 | 0.69 |
| EBIT Margin | -0.10 | 0.03 | -0.09 | -0.01 | - | 0.09 |
| Profit Margin | -0.11 | -0.06 | -0.12 | -0.10 | 0.04 | 0.06 |
| EBITDA | -54.51 Million | 16.19 Million | -49.96 Million | -9.69 Million | - | 57.33 Million |
| Earnings Before Tax Margin | -0.10 | -0.07 | -0.12 | -0.10 | 0.05 | 0.07 |
RFK
002069
ERA
YUMAQ
RAJPUTANA
STANCAP